Related Experiment Video
Updated: Feb 14, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
Primary Sclerosing Cholangitis: Diagnosis, Management, and Clinical Challenges
Sofia Svensson Di Giorgio1, Chiara Maria Scandavini1, Antonio Molinaro2
1Department of Diagnostics and Intervention, Surgery, Umeå University, 901 87 Umeå, Sweden.
Primary sclerosing cholangitis (PSC) is a rare, progressive liver disease impacting the bile ducts. This review offers clinical insights into PSC diagnosis and management challenges.
Area of Science:
- Hepatology
- Gastroenterology
- Immunology
Background:
- Primary sclerosing cholangitis (PSC) is a chronic, inflammatory biliary disease.
- It leads to bile duct obliteration, liver dysfunction, cirrhosis, and serious complications like cholangiocarcinoma.
- The rising global prevalence of PSC presents diagnostic and management challenges.
Purpose of the Study:
- To provide a clinically focused review of PSC diagnosis and management.
- To highlight current challenges and uncertainties in treating PSC patients.
Main Methods:
- Literature review focusing on clinical diagnosis and management strategies for PSC.
- Synthesis of current evidence regarding PSC epidemiology, complications, and treatment.
Main Results:
- PSC is a rare but increasingly prevalent condition requiring specialized care.
- Early diagnosis and comprehensive management are crucial for improving patient outcomes.
- Significant challenges remain in understanding PSC pathogenesis and developing targeted therapies.
Conclusions:
- PSC management requires a multidisciplinary approach, addressing its progressive nature and complications.
- Further research is needed to clarify PSC etiology and optimize treatment strategies.
- Addressing diagnostic and therapeutic uncertainties is key to improving care for patients with PSC.
More Related Videos
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Related Concept Videos
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Acute Pancreatitis II: Clinical Manifestations and Management